Pre-treatment with α-tocopherol and terminalia arjuna ameliorates, pro-inflammatory cytokines, cardiac and apoptotic markers in myocardial infracted rats

Redox Report

Volumn 20, Issue 2, 2015, Pages 49-59

  Shukla, Santosh K ^a   Sharma, Suman B ^b   Singh, Usha R ^b  

^a HLL LIFECARE LIMITED   (India)

^b UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Isoproterenol; Myocardial infarction; Oxidative stress; Pro inflammatory cytokines; Terminalia arjuna

Indexed keywords

ALPHA TOCOPHEROL; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATINE KINASE MB; CYTOKINE; INTERLEUKIN 6; ISOPRENALINE; LACTATE DEHYDROGENASE; MALONALDEHYDE; PROTEIN BAX; PROTEIN BCL 2; TERMINALIA ARJUNA EXTRACT; TUMOR NECROSIS FACTOR ALPHA; BAX PROTEIN, RAT; CARDIOTONIC AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART PROTECTION; HISTOPATHOLOGY; INFLAMMATION; LIPID PEROXIDATION; MALE; NICK END LABELING; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; RAT; THIN LAYER CHROMATOGRAPHY; ANIMAL; CHEMISTRY; DRUG EFFECTS; METABOLISM; MUSCLE CELL; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PATHOLOGY; PROCEDURES; TERMINALIA; WISTAR RAT;

RATTUS; TERMINALIA ARJUNA;

ALPHA-TOCOPHEROL; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARDIOTONIC AGENTS; CHROMATOGRAPHY, THIN LAYER; CYTOKINES; INFLAMMATION; ISOPROTERENOL; LIPID PEROXIDATION; MALE; MUSCLE CELLS; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; PLANT EXTRACTS; RATS, WISTAR; TERMINALIA;

EID: 84922825345     PISSN: 13510002     EISSN: 17432928     Source Type: Journal    
DOI: 10.1179/1351000214Y.0000000104     Document Type: Article

References (51)

1. Alwan A, MacLean DR, Riley LM, d’Espaignet ET, Mathers CD, Stevens GA, et al. Monitoring and surveillance of chronic non communicable diseases: progress and capacity in high-burden countries. Lancet 2010;376:1861-8.
2. Gilski DJ, Borkenhagen B. Risk evaluation in action for cardiovascular health. Crit Care Nurse 2005;25:26-37.
3. Panda VS, Naik SR. Cardio protective activity of Gingko biloba phytosomes in isoproterenol induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. Exp Toxicol Pathol 2008;60:397–404.
4. Kannan MM, Quine SD. Ellagic acid ameliorates isoproterenol induced oxidative stress: evidence from electro cardiological, biochemical and histological study. Eur J Pharmacol 2011;659: 45-52.
5. Kagan VE, Serbinova EA, Forte T, Scita G, Packer L. Recycling of vitamin E in human low density lipoproteins. J Lipid Res 1992;33:385-97.
6. Yogeeta SK, Balaji HBR, Gnana pragasam A, Senthilkumar S, Subhashini R, Devaki T. Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid. Basic Clin Pharmacol Toxicol 2006;98: 467-72.
7. Punithavathi VR, Prince SM. Combined effects of quercetin and a-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats. Chem Biol Interact 2009;181:322-7.
8. Pour ZM, Zal F, Monabati A, Vessal MO. Protective effects of a combination of quercetin and vitamin E against cyclosporine A-induced oxidative stress and hepatotoxicity in rats. Hepatol Res 2008;38:385-92.
9. Dwivedi S. Terminalia arjuna Wight & Arn - a useful drug for cardiovascular disorders. J Ethnopharmacol 2007;7:114-29.
10. Gauthaman K, Maulik M, Kumari R, Manchanda SC. Effect of chronic treatment with bark of Terminalia arjuna: a study on the isolated ischemic-reperfused rat heart. J Ethnopharmacol 2001;75:197-201.
11. Smolarek AK, Suh N. Chemopreventive activity of vitamin E in breast cancer: a focus on y and 8 tocopherol. Nutrients 2011;3:962.
12. Sen CK, Khanna S, Roy S. Tocoterienol: the natural vitamin E to defend the nervous system. Ann NY Acad Sci 2004;1031:127.
13. Trease GE, Evans WC. Pharmacognosy. 13th ed. English Language Book Society, Britain: Bailliere Tindall; 1989. vol. 378, p. 386–480.
14. Evans WC, Evans T. Pharmacognosy. 5th ed. London: Cambridge University Press; 2003. vol. 336, p. 93.
15. Harborne JB. Phytochemical methods. London: Chapman and Hall Ltd; 1973. p. 49-188.
16. Harborne JB. Phytochemical methods. A guide O modern techniques of plant analysis, Chapman and Hall. J Sci Res 2009;1: 393-8.
17. Sofowora A. Medicinal plants and traditional medicine in Africa. Ibadan: Spectrum Books; 1993. p. 150.
18. Singh M, Kamal YKT, Parveen R, Ahmad S. Development and validation of a stability-indicating HPTLC method for analysis of arjunolic acid in an herbal formulation. J Planar Chromatogr 2011;24:172-5.
19. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 1959;67:443-55.
20. Mohanty I, Arya DS, Dinda A, Talwar KK. Protective effects of Curcuma longa on ischemia-reperfusion induced myocardial injuries and their mechanisms. Life Sci 2004;75:1701-11.
21. Goyal SN, Arora S, Sharma AK, Joshi S, Ray R, Bhatia J. Preventive effect of crocin of Crocus sativus on hemodynamic, biochemical, histopathological and ultrastuctural alterations in isoproterenol-induced cardiotoxicity in rats. Phytomedicine 2010;17:227-32.
22. Satoh K. Serum lipid peroxide in cerebrovascular disorder determined by a new colorimetric method. Clin Chem Acta 1978;90: 37–43.
23. Marklund S, Marklund G Involvement of the superoxide anion radical in the autooxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974;47:469-74.
24. Nandi A, Chatterjee B. Assay of superoxide dismutase activity in animal tissues. J Biosci 1988;13:305-15.
25. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
26. Gavrieli Y, Sherman Y, Ben Sasson SA. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
27. Gorczyca W, Gong J, Darzynkiewicz Z. Detection of DNA strand breaks in individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res 1993;53:1945-51.
28. Van Acker FAA, Schouten O, Haenen GRMM, Van der Vijgh WJF, Bast A. Flavonoids can replace a-tocopherol as an antioxidant. FEBS Lett 2000;473:145-8.
29. Van den Berg R, Haenen RMM, Van den Berg H, Bast A. Applicability of an improved Trolox equivalent antioxidant capacity (TEAC) assay for evaluation of antioxidant capacity measurements of mixtures. Food Chem 1999;66:511-7.
30. Geronikaki AA, Gavalas AM. Antioxidant and anti-inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 2006;9: 425-42.
31. Sumitra M, Manikandan P, Dilly AK, Natrajan A, Kedike B, Manohar BM, et al. Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol Cell Biochem 2001;224:135–42.
32. Kumar S, Enjamoori R, Jaiswal A, Ray R, Seth S, Maulik SK, et al. Catecholamine induced myocardial fibrosis and oxidative stress is attenuated by Terminalia arjuna (Roxb.). J Pharm Pharmacol 2009;61:1529-36.
33. Verlangieri AJ, Bush MJ. Effect of dl-(±)-of a-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992;11:131-8.
34. Singh RB, Niaz MA, Rastogi SS, Rastogi S. Usefulness of antioxidant vitamins in suspected acute myocardial infarction (the Indian experiment of infarct survival-3). Am J Cardiol 1996; 77:232-6.
35. McMurray J, Mclay J, Chopra M, Bridges A, Belch JJ. Evidence for enhanced free radical activity in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1990;65:1261-2.
36. Diaz-Velez CR, Garcia-Castineiras S, Mendoza-Ramos E, Hernandez-Lopez E. Increased malondialdehyde in peripheral blood of patients with congestive heart failure. Am Heart J 1996;131:146-52.
37. Stephens NG, Parsons A, Schofield PM. Randomised controlled trail of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996;347:781-6.
38. Blasig IE, Blasig R, Lowe H. Myocardial lipid peroxidation during isoproterenol-induced blood flow reduction in rat myocardium. Biomed Biochim Acta 1984;43:171-4.
39. Pathania V, Syal N, Hundal MH, Khanduja KL. Geriforte stimulates antioxidant defense system. Indian J Exp Biol 1998; 36:414-7.
40. Banerjee SK, Dinda AK, Manchanda SC, Maulik SK. Chronic garlic administration protects rat heart against oxidative stress induced by ischemic reperfusion injury. BMC Pharmacol 2002; 29:16.
41. Manjula TS, Geetha A, Shyamala Devi CS. Effect of aspirin on isoproterenol induced myocardial infarction - a pilot study. Indian J Biochem Biophys 1992;29:378-9.
42. Geetha A, Sankar R, Thankamani M, Shyamala Devi CS. a-Tocopherol reduces doxorubicin induced toxicity in rats -histological and biochemical evidences. Indian J Physiol Pharmacol 1990;34:94-100.
43. Rona G Catecholamine cardiotoxicity. J Mol Cell Cardiol 1985; 17:291-306.
44. Rona G, Chappel CI, Balazs T, Gaudry R. An infarct like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Arch Pathol 1959;67:443-55.
45. Kajstura J, Chong W, Sarangarajan R, Li P. Necrotic and apoptotic myocyte cell death in the aging heart of Fischer-344 rats. Am J Physiol 1996;271:1215-28.
46. Bartling B, Holtz J, Darmer D. Contribution of myocyte apoptosis to myocardial infarction. Basic Res Cardiol 1998;93: 71-84.
47. MacLellan WR, Schneider MD. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 1997; 81:137–44.
48. Haunstetter A, Izumo S. Apoptosis: basic mechanisms and implications for cardiovascular disease. Circ Res 1998;82: 1111-29.
49. Saraste A, Pulkki K, Kallajoki M, Henriksen K. Apoptosis in human acute myocardial infarction. Circulation 1997;95: 320-3.
50. Zhou B, Wu LJ, Li LH, Tashiro S. Silibinin protects against isoproterenol-induced rat cardiac myocyte injury through mitochondrial pathway after up-regulation of SIRT1. Pharmacol Sci 2006;102:387-95.
51. Chen G, Zhou X, Florea S, Qian J. Expression of active protein phosphatase 1 inhibitor-1 attenuates chronic beta-agonist-induced cardiac apoptosis. Basic Res Cardiol 2010;105:573-81.